You sit down to work and the words won't come. You re-read the same paragraph three times and retain nothing. You walk into a room and immediately forget why. You search for a word. A simple, familiar word, and it just isn't there. Your GP runs blood work, calls you back, and tells you everything looks fine.
This is one of the most common, and most frustrating, experiences in modern medicine. Persistent cognitive symptoms without a clear diagnosis. The clinical term nobody uses in the GP's office is brain fog: a symptom cluster involving impaired attention, slowed processing speed, word-retrieval failure, and short-term memory gaps that can't be explained by neurological disease, medication side effects, or obvious psychological causes.
There are at least six measurable, correctable physiological causes of brain fog that standard blood panels almost never test for. They are all detectable from a single blood draw. And in many cases, correcting them resolves the symptoms entirely.
Brain fog is not a medical diagnosis. It is a symptom pattern. Patients describe it as mental fatigue that doesn't resolve with sleep, difficulty concentrating even on familiar tasks, slowed thinking, and a sense of being mentally "underwater." It often coexists with physical fatigue, mood changes, and normal results on routine blood work.
That last point is the source of enormous frustration. When standard results come back normal and symptoms persist, patients are often told it's stress, anxiety, or "just how it is." But "normal" and "optimal" are not the same thing and the markers most relevant to cognitive function are precisely the ones not on a standard panel.
The großes Blutbild, which many people request hoping for a comprehensive health assessment, tests your blood cells. It tells you almost nothing about the hormonal, nutritional, or inflammatory status that governs how your brain actually functions. We've covered this gap in detail elsewhere. The Check-up 35 covers five values and none of them address cognitive function directly.
The result: millions of people with reversible, physiological causes of poor concentration never receive a clear answer, because nobody has looked at the right markers.
Brain fog with a physiological cause is fundamentally different from structural neurological decline. The former is often fully reversible when the underlying driver is identified and addressed. The latter involves progressive changes to brain tissue and is not. This distinction matters enormously, and it is the reason early, comprehensive testing is so valuable.
Iron deficiency is the most prevalent single-nutrient deficiency in Europe. Among women of reproductive age, estimates range from 15–30%. [1] But here is the part that most people, and many GPs, don't appreciate: you can have critically depleted iron stores while your standard blood count looks completely normal.
The großes Blutbild tests haemoglobin, the emergency measure. Haemoglobin only falls after iron stores are severely depleted. Ferritin, which measures those iron stores directly, falls first. The gap between the two can span months or years of progressive cognitive and physical impairment, during which time every blood test comes back "fine."
Iron is essential for myelin synthesis (the insulating sheath around nerve fibres), dopamine production, and cellular energy metabolism. The brain is iron-dependent in ways that make low ferritin particularly damaging to cognition. Iron deficiency specifically impairs attention span, processing speed, and working memory — the cognitive domains most commonly reported as impaired in brain fog.
A randomised, placebo-controlled trial by Murray-Kolb and Beard examined cognitive performance in women with varying iron status. After treatment, a significant improvement in serum ferritin was associated with a 5–7-fold improvement in cognitive performance on accuracy tasks. A significant improvement in haemoglobin, by contrast, primarily improved processing speed, not accuracy. [2] The implication is direct: it is ferritin, not haemoglobin, that determines cognitive precision.
Laboratory reference ranges for ferritin typically begin at 12–15 µg/L. Functional medicine practitioners, and an increasing body of evidence, suggest that optimal ferritin for cognitive and neurological function sits between 50–100 µg/L. [3] The gap, from 12 to 50, is where millions of people live with measurable symptoms that no standard test catches.
A 2025 systematic review and meta-analysis found that iron supplementation in iron-deficient but non-anaemic individuals improved cognitive intelligence (effect size d = 0.46) and short-term memory (d = 0.53). [4] These are meaningful effects. But they only become available to you once you know your ferritin level — and that is not on the großes Blutbild.
Aniva tests ferritin alongside the full iron panel, serum iron and transferrin saturation, as standard. Because measuring haemoglobin alone is not testing your iron status. See the full biomarker panel →
Thyroid hormone governs metabolic rate throughout the body, including in the brain. Every neuron depends on thyroid hormone to function efficiently. When thyroid output is insufficient, the result is cognitive slowing: poor memory, reduced processing speed, difficulty concentrating, and a pattern of symptoms that looks almost identical to brain fog from other causes.
Thyroid dysfunction is far more common than most people realise. Subclinical hypothyroidism, where TSH is elevated but still within broadly defined normal ranges, affects an estimated 3.8–20% of the population, with prevalence increasing with age. [5]
Overt, undiagnosed hypothyroidism affects roughly 0.33–0.82% of adults. Autoimmune thyroid disease (Hashimoto's thyroiditis) is the most common cause of hypothyroidism in Europe and can cause significant cognitive symptoms while TSH appears completely normal.
TSH (thyroid-stimulating hormone) is the standard screening marker. But TSH reflects the pituitary's signal to the thyroid, not the amount of active thyroid hormone actually reaching your cells.
Two other markers complete the picture: free T4 (the stored precursor hormone produced by the thyroid) and free T3 (the biologically active form that cells actually use). The conversion of T4 to T3 happens in peripheral tissue and can be impaired by chronic stress, iron deficiency, selenium deficiency, and inflammation — all independently. A person can have a perfectly normal TSH and still have impaired T4-to-T3 conversion that drives cognitive symptoms.
Thyroid antibodies, TPO-Ab and Tg-Ab, tell you whether autoimmune thyroiditis is present, even before TSH moves. In Hashimoto's thyroiditis, antibody levels rise and cognitive symptoms appear before the thyroid shows measurable dysfunction on standard panels. This means that screening TSH alone misses a significant proportion of thyroid-related brain fog.
A 2022 narrative review published in Thyroid by Samuels and Bernstein surveyed 5,170 patients with hypothyroidism who reported brain fog. Of these, 79.2% experienced brain fog symptoms frequently or all the time. More than 95% reported fatigue, forgetfulness, sleepiness, and lack of focus as the most common symptoms. [6] Notably, 46.6% reported that their cognitive symptoms predated their hypothyroidism diagnosis, meaning the brain effects emerged before standard clinical thresholds were crossed.
The clinical lesson: if your concentration is impaired, a TSH alone is not a thyroid assessment. You need TSH, free T4, free T3, and thyroid antibodies. The first test tells you one number. The full panel tells you what is actually happening.
Vitamin D is frequently discussed in the context of bones and immune function. Its role in cognitive performance is less well known, but the evidence is substantial, and the relevance to the German population is particularly acute.
Vitamin D is not technically a vitamin. It behaves as a steroid hormone, regulating the expression of over 1,000 genes. The brain contains vitamin D receptors throughout in the hippocampus (memory formation), the prefrontal cortex (attention and executive function), and the cerebellum (coordination and processing speed). Deficiency disrupts neurotransmitter synthesis, including dopamine and serotonin pathways central to motivation, focus, and mood regulation.
Meaningful cutaneous vitamin D synthesis requires UV-B radiation at an angle above 35 degrees. In Germany, this is essentially impossible between October and March. The Robert Koch Institut's DEGS1 study found that approximately 56% of German adults have vitamin D levels below 50 nmol/L, the level associated with meaningful physiological function. [7] Among adults who work indoors or use sunscreen regularly, deficiency is close to universal during winter months.
The standard clinical threshold for "sufficiency" is 20 nmol/L: a level set to prevent bone disease, not to support optimal neurological function. Research on cognitive performance and neurological outcomes consistently suggests that 50–80 nmol/L is the functional optimum for adults seeking to maintain brain health. [8] The gap between "not deficient" and "optimal" is where most of the action is.
Supplementing without testing is not a solution. Vitamin D levels vary dramatically between individuals based on sun exposure, skin pigmentation, body composition, and baseline status. Someone deficient may need 4,000 IU/day to reach optimal levels; someone already at 70 nmol/L risks pushing into excess with the same dose. The only way to supplement precisely is to know your level first, and then retest after a few months to confirm you've reached the right range. We cover this in depth in our article on vitamin D in Northern Europe.
Aniva's panel includes vitamin D alongside its key cofactors, magnesium and calcium, because vitamin D status doesn't exist in isolation. €199/year. Join the waitlist →
Vitamin B12 is essential for myelin integrity (the same insulating structure that iron supports), for DNA synthesis in neurons, and for the conversion of homocysteine to methionine — a process central to neurotransmitter production. When B12 is insufficient, neurological function degrades — often well before any haematological changes appear.
This is the underappreciated clinical problem with B12. The classic diagnostic signals like megaloblastic anaemia, detectable on a großes Blutbild, is a late manifestation.
Cognitive and neurological symptoms from B12 insufficiency frequently precede anaemia by months or years. Lindenbaum et al. found that 40 out of 141 patients with confirmed B12 deficiency had neuropsychiatric abnormalities without anaemia. [9] The blood count appeared normal; the nervous system was already compromised.
Standard laboratory cut-offs define B12 deficiency at below 150–200 pg/mL. But evidence suggests this threshold is set too conservatively for neurological outcomes. Vitamin B12 levels in the sub-clinical low-normal range below 250 pg/mL are associated with Alzheimer's disease, vascular dementia, and Parkinson's disease. [10] Some researchers argue that 350 pg/mL is a more appropriate threshold for neurological protection — more than twice the standard deficiency cut-off.
The homocysteine connection amplifies this. B12 and folate are required for homocysteine metabolism. When either is insufficient, homocysteine accumulates. Elevated homocysteine is itself an independent risk factor for cognitive impairment, vascular damage, and neurodegeneration — and it is measurable. A combined assessment of B12, folate, and homocysteine provides a far more sensitive picture of actual B12 status and its neurological implications than serum B12 alone. [11]
B12 deficiency is particularly prevalent in older adults (absorption declines with age due to reduced intrinsic factor production), strict vegetarians and vegans (B12 is found almost exclusively in animal products), and people taking metformin long-term (which impairs B12 absorption). None of these groups are specifically flagged by standard blood panels unless B12 is explicitly tested, which it routinely isn't.
Inflammation is not just something you feel in an injured joint. Chronic low-grade systemic inflammation is detectable in the bloodstream as elevated hs-CRP (high-sensitivity C-reactive protein). It has emerged as a significant independent driver of cognitive impairment. The mechanism is neuroinflammatory: peripheral inflammatory signals cross the blood-brain barrier, activate microglia (the brain's immune cells), and disrupt neurotransmitter synthesis and synaptic function.
A 2022 systematic review and meta-analysis (examining 2,188 articles across PubMed, Embase, and Web of Science) found that high levels of peripheral CRP predict progression from normal cognition to cognitive decline or dementia, including specifically to vascular dementia (hazard ratio 2.769, 95% CI: 1.586–4.83). [12]
This is not a minor signal. Elevated hs-CRP in middle age is associated with measurable neurochemical changes even in individuals with normal cognitive functioning: detectable years before any clinical symptoms emerge. [13]
The important distinction about hs-CRP is that it responds to lifestyle modification. Chronic sleep deprivation is the single largest modifiable driver of elevated CRP in otherwise healthy adults. Ultra-processed food consumption, sedentary behaviour, and chronic psychological stress all independently elevate it. Conversely, consistent moderate exercise, Mediterranean dietary patterns, and restorative sleep all reduce it: measurably, over months.
Under 1.0 mg/L represents low systemic inflammatory risk. Between 1.0 and 3.0 mg/L, lifestyle factors are worth investigating. Above 3.0 mg/L, the signal warrants clinical attention. If you've never tested hs-CRP, you don't know your inflammatory baseline, and if it's elevated, you have no reference point against which to track whether your interventions are working.
This is the practical value of the marker: not just as a risk indicator, but as a feedback mechanism. It makes "reduce inflammation" a measurable goal rather than a vague aspiration. Read more about hs-CRP and what drives it in our biomarker series.
The relationship between cortisol and cognitive performance is well established in the research literature, if poorly communicated in clinical practice. Cortisol is your primary stress hormone, but it is also your brain's primary glucocorticoid, governing memory consolidation, executive function, and the regulation of inflammatory signalling in the central nervous system.
Under normal physiological conditions, cortisol follows a diurnal rhythm: peaking sharply within 30–45 minutes of waking (the Cortisol Awakening Response), then declining steadily through the day to a nadir at midnight. This rhythm is the daily architecture of your cognitive performance. Disruption to it through chronic stress; sleep dysregulation; or HPA axis dysfunction; produces cognitive symptoms that are remarkably consistent with brain fog: slow morning cognition, mid-afternoon energy and attention crashes, and paradoxical mental alertness late at night when the system should be winding down.
A standard cortisol blood test, if ordered at all, captures a single snapshot. But cognitive symptoms arise from pattern dysregulation, not from a single elevated or depressed value. Flattened cortisol curves, where the awakening peak is blunted and the diurnal decline absent, produce persistent low-grade mental fog even when an individual reading falls within normal range.
This is one reason why cognitive symptoms that correlate with chronic stress are so frequently missed: the test used to investigate them doesn't assess what actually matters. We've covered cortisol in full detail in our dedicated article.
Additionally, cortisol interacts with thyroid function, with ferritin status, and with inflammatory markers. Chronic HPA axis dysregulation suppresses T4-to-T3 conversion, worsens insulin sensitivity, and elevates hs-CRP. These interactions mean that assessing cortisol in isolation, without the surrounding hormonal and metabolic context, limits what you can conclude from any single result.
Aniva's 100+ biomarker panel assesses all six of these markers in context — not as isolated values but as an interconnected picture of your physiology. One blood draw. One annual report. Clear, personalised interpretation. See what's included →
None of the six biomarkers covered in this article appear on a standard großes Blutbild. Ferritin, thyroid panel with antibodies, vitamin D, B12, hs-CRP, and cortisol are each individually available from a GP, but only when specifically requested, and typically only when there is a documented clinical indication. For a patient who presents with concentration difficulties and no other findings, the systemic response is to order the standard panel, find nothing, and attribute the symptoms to stress or lifestyle.
This is not a failure of individual GPs. It is a structural feature of a healthcare system designed for disease detection, not preventive optimisation. The Check-up 35 covers five markers every three years. The großes Blutbild covers blood cell morphology. Neither was designed to address the question: "Why can't I concentrate?"
There is a second problem beyond individual marker gaps: these markers interact. Iron deficiency worsens thyroid function by impairing T4-to-T3 conversion. Low vitamin D elevates inflammatory tone.
Chronic cortisol dysregulation depletes B12 more rapidly. Elevated homocysteine, driven by B12 and folate insufficiency, directly damages vascular integrity in the brain. Addressing one marker in isolation, without understanding the others, is diagnostically incomplete. The picture these six markers paint together is significantly richer than any single result.
If you are experiencing persistent concentration difficulties, word-retrieval problems, or mental fatigue that isn't explained by obvious lifestyle factors, the starting point may be is not a referral to a neurologist.
It could be a deeper blood panel that specifically includes: ferritin (not just haemoglobin) with a target optimal range of 50–100 µg/L; a full thyroid panel with TSH, free T4, free T3, TPO antibodies, and thyroglobulin antibodies; vitamin D (25-OH) with an optimal target of 50–80 nmol/L; vitamin B12 and folate alongside homocysteine as an integrative marker of B-vitamin status; hs-CRP for baseline systemic inflammatory load; and cortisol in the context of the broader hormonal picture, not as a standalone snapshot.
This is not an exhaustive list. Blood sugar regulation, specifically fasting insulin and HbA1c, also significantly impacts cognitive performance through the mechanism of insulin resistance in the brain. Testosterone and SHBG affect concentration and mental drive, particularly in men over 35 and in women experiencing hormonal transition. But the six above represent the most common, most correctable, and most consistently overlooked causes of brain fog in otherwise healthy adults.
The key word in all of this is correctable. These are not irreversible conditions. They are measurable nutritional, hormonal, and inflammatory imbalances that respond to targeted intervention, once you know they exist.
Brain fog is not a personality trait. Konzentrationsprobleme are not evidence of weakness or burnout alone. In a significant proportion of cases, cognitive symptoms have a physiological driver that can be identified with a blood test and addressed directly.
The six markers in this article: ferritin; thyroid function; vitamin D; B12; hs-CRP; and cortisol, are all measurable from a single blood draw. They are all interpretable against evidence-based optimal ranges, not just population reference ranges. And they are all actionable: deficiencies are correctable, inflammation is modifiable, and hormonal patterns can be tracked and improved over time.
What you need is not another round of standard blood work that tells you everything looks fine. You need the right markers, assessed together, interpreted in context.
Ferritin below 50 µg/L causes brain fog in non-anaemic adults, and won't appear on a großes Blutbild. Thyroid dysfunction can be active while TSH looks normal, only the full panel reveals it. 56% of German adults are below optimal vitamin D levels, most have never tested. B12 neurological symptoms precede haematological changes by months or years. Elevated hs-CRP is a measurable, modifiable driver of impaired cognitive function. Cortisol dysregulation disrupts the entire cognitive architecture of your day.
Testing these six markers together, in context, against optimal rather than minimal thresholds, is what a genuine answer to Konzentrationsprobleme looks like.
Aniva tests 100+ biomarkers annually — including all six covered in this article — at an ISO 15189-certified German laboratory. Results include personalised interpretation and an action plan, not just a list of numbers. €199/year. Join the waitlist →
[1] Pasricha SR, et al. "Iron deficiency without anaemia: a diagnosis that matters." Internal Medicine Journal. 2021;51(2):168-173. PubMed
[2] Murray-Kolb LE, Beard JL. "Iron treatment normalizes cognitive functioning in young women." American Journal of Clinical Nutrition. 2007;85(3):778-787. PubMed
[3] Vaucher P, et al. "Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin." CMAJ. 2012;184(11):1247-1254. PMC
[4] Ruíz-Sánchez JM, et al. "Psychiatric and cognitive outcomes of iron supplementation in non-anemic children, adolescents, and menstruating adults: A meta-analysis." Neuroscience & Biobehavioral Reviews. 2025. ScienceDirect
[5] Mendes D, et al. "Prevalence of undiagnosed hypothyroidism in Europe." European Thyroid Journal. 2019;8(3):130-143. PubMed
[6] Samuels MH, Bernstein LJ. "Brain fog in hypothyroidism: What is it, how is it measured, and what can be done about it." Thyroid. 2022;32(7):752-763. PMC
[7] Rabenberg M, et al. "Vitamin D status among adults in Germany: DEGS1." BMC Public Health. 2015;15:641. PubMed
[8] Cashman KD, et al. "Vitamin D deficiency in Europe: pandemic?" American Journal of Clinical Nutrition. 2016;103(4):1033-1044. PubMed
[9] Lindenbaum J, et al. "Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis." New England Journal of Medicine. 1988;318(26):1720-1728. PubMed
[10] Wald DS, et al. "Cognitive impairment and vitamin B12: a review." International Psychogeriatrics. 2012;24(4):541-556. PubMed
[11] Homocysteine Studies Collaboration. "Homocysteine and risk of ischemic heart disease and stroke." JAMA. 2002;288(16):2015-2022. PubMed
[12] Zhou Z, et al. "Peripheral high levels of CRP predict progression from normal cognition to dementia." Journal of the Neurological Sciences. 2023;445:120540. ScienceDirect
[13] Eagan DE, et al. "Elevated serum C-reactive protein relates to increased cerebral myoinositol and cognitive vulnerability in middle-aged adults." Cardiovascular Psychiatry and Neurology. 2012. PubMed
[14] Ettleson MD, et al. "Brain fog in hypothyroidism: understanding the patient's perspective." Endocrine Practice. 2022;28(3):257-264. PMC
[15] Jatoi S, et al. "Low vitamin B12 levels: an underestimated cause of minimal cognitive impairment and dementia." Cureus. 2020;12(2):e6976. PMC
This content is for informational purposes only and is not medical advice. Always discuss results with a qualified healthcare professional. Cognitive symptoms may have multiple causes, including conditions that require clinical evaluation. If you are experiencing significant cognitive changes, consult your doctor.
